BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 34140640)

  • 1. Cell-type deconvolution analysis identifies cancer-associated myofibroblast component as a poor prognostic factor in multiple cancer types.
    Li B; Pei G; Yao J; Ding Q; Jia P; Zhao Z
    Oncogene; 2021 Jul; 40(28):4686-4694. PubMed ID: 34140640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular classification of cancer-associated fibroblasts on a pan-cancer single-cell transcriptional atlas.
    Chen B; Chan WN; Xie F; Mui CW; Liu X; Cheung AHK; Lung RWM; Chow C; Zhang Z; Fang C; Yu P; Shi S; Zhou S; Chen G; Wang Z; Wang S; Ding X; Huang B; Liang L; Dong Y; Wong CC; Wu WKK; Cheng ASL; Wong N; Yu J; Lo KW; Tse GMK; Kang W; To KF
    Clin Transl Med; 2023 Dec; 13(12):e1516. PubMed ID: 38148640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The collagen landscape in cancer: profiling collagens in tumors and in circulation reveals novel markers of cancer-associated fibroblast subtypes.
    Thorlacius-Ussing J; Jensen C; Nissen NI; Cox TR; Kalluri R; Karsdal M; Willumsen N
    J Pathol; 2024 Jan; 262(1):22-36. PubMed ID: 37728068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subpopulations of cancer-associated fibroblasts link the prognosis and metabolic features of pancreatic ductal adenocarcinoma.
    Hu B; Wu C; Mao H; Gu H; Dong H; Yan J; Qi Z; Yuan L; Dong Q; Long J
    Ann Transl Med; 2022 Mar; 10(5):262. PubMed ID: 35402584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pan-cancer analyses and molecular subtypes based on the cancer-associated fibroblast landscape and tumor microenvironment infiltration characterization reveal clinical outcome and immunotherapy response in epithelial ovarian cancer.
    Zou R; Jiang Q; Jin T; Chen M; Yao L; Ding H
    Front Immunol; 2022; 13():956224. PubMed ID: 36032075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the devil: Strategies against cancer-associated fibroblasts in colorectal cancer.
    Chen Y; Liang Z; Lai M
    Transl Res; 2024 Aug; 270():81-93. PubMed ID: 38614213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Features of Cancer-associated Fibroblast Subtypes and their Implication on Cancer Pathogenesis, Prognosis, and Immunotherapy Resistance.
    Galbo PM; Zang X; Zheng D
    Clin Cancer Res; 2021 May; 27(9):2636-2647. PubMed ID: 33622705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analyses of the cancer-associated fibroblast subtypes and their score system for prediction of outcomes and immunosuppressive microenvironment in prostate cancer.
    Gao Z; Zhang N; An B; Li D; Fang Z; Xu D
    Cancer Cell Int; 2024 Apr; 24(1):127. PubMed ID: 38580966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of steady-state fibroblast subtypes in the normal human breast as cells-of-origin for perturbed-state fibroblasts in breast cancer.
    Bagger MM; Sjölund J; Kim J; Kohler KT; Villadsen R; Jafari A; Kassem M; Pietras K; Rønnov-Jessen L; Petersen OW
    Breast Cancer Res; 2024 Jan; 26(1):11. PubMed ID: 38229104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cancer-associated fibroblast gene signature predicts prognosis and therapy response in patients with pancreatic cancer.
    Zhang J; Chen M; Fang C; Luo P
    Front Oncol; 2022; 12():1052132. PubMed ID: 36465388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-Cell Transcriptomic Analysis of Tumor-Derived Fibroblasts and Normal Tissue-Resident Fibroblasts Reveals Fibroblast Heterogeneity in Breast Cancer.
    Sebastian A; Hum NR; Martin KA; Gilmore SF; Peran I; Byers SW; Wheeler EK; Coleman MA; Loots GG
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32455670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residual ANTXR1+ myofibroblasts after chemotherapy inhibit anti-tumor immunity via YAP1 signaling pathway.
    Licaj M; Mhaidly R; Kieffer Y; Croizer H; Bonneau C; Meng A; Djerroudi L; Mujangi-Ebeka K; Hocine HR; Bourachot B; Magagna I; Leclere R; Guyonnet L; Bohec M; Guérin C; Baulande S; Kamal M; Le Tourneau C; Lecuru F; Becette V; Rouzier R; Vincent-Salomon A; Gentric G; Mechta-Grigoriou F
    Nat Commun; 2024 Feb; 15(1):1312. PubMed ID: 38346978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of the biology and therapeutic implications of cancer-associated fibroblasts (CAFs) in muscle-invasive bladder cancer.
    Burley A; Rullan A; Wilkins A
    Front Oncol; 2022; 12():1000888. PubMed ID: 36313650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma.
    Neuzillet C; Tijeras-Raballand A; Ragulan C; Cros J; Patil Y; Martinet M; Erkan M; Kleeff J; Wilson J; Apte M; Tosolini M; Wilson AS; Delvecchio FR; Bousquet C; Paradis V; Hammel P; Sadanandam A; Kocher HM
    J Pathol; 2019 May; 248(1):51-65. PubMed ID: 30575030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive bioinformatic analysis reveals a cancer-associated fibroblast gene signature as a poor prognostic factor and potential therapeutic target in gastric cancer.
    Ucaryilmaz Metin C; Ozcan G
    BMC Cancer; 2022 Jun; 22(1):692. PubMed ID: 35739492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposed drug screen identifies cardiac glycosides as inhibitors of TGF-β-induced cancer-associated fibroblast differentiation.
    Coleman DT; Gray AL; Stephens CA; Scott ML; Cardelli JA
    Oncotarget; 2016 May; 7(22):32200-9. PubMed ID: 27058757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated single-cell and bulk RNA sequencing analysis identifies a cancer associated fibroblast-related signature for predicting prognosis and therapeutic responses in colorectal cancer.
    Zheng H; Liu H; Ge Y; Wang X
    Cancer Cell Int; 2021 Oct; 21(1):552. PubMed ID: 34670584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional heterogeneity of cancer-associated fibroblasts from human colon tumors shows specific prognostic gene expression signature.
    Herrera M; Islam AB; Herrera A; Martín P; García V; Silva J; Garcia JM; Salas C; Casal I; de Herreros AG; Bonilla F; Peña C
    Clin Cancer Res; 2013 Nov; 19(21):5914-26. PubMed ID: 24052018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deciphering the spatial landscape and plasticity of immunosuppressive fibroblasts in breast cancer.
    Croizer H; Mhaidly R; Kieffer Y; Gentric G; Djerroudi L; Leclere R; Pelon F; Robley C; Bohec M; Meng A; Meseure D; Romano E; Baulande S; Peltier A; Vincent-Salomon A; Mechta-Grigoriou F
    Nat Commun; 2024 Apr; 15(1):2806. PubMed ID: 38561380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct fibroblast subpopulations associated with bone, brain or intrapulmonary metastasis in advanced non-small-cell lung cancer.
    Xu K; Wang H; Zou YX; Zhang HH; Wang YN; Ren XR; Wang HQ; Xu YH; Li JJ; Tang H; He C; Wei S; Tian T; Li LL; Zhou H; Xu LJ; Fang JW; Guo C; Yang JX; Zhou YY; Zhang ZH; Pan YY
    Clin Transl Med; 2024 Mar; 14(3):e1605. PubMed ID: 38445456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.